BioGraph 55, Inc. Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
BioGraph 55, Inc. is a San Francisco based early-stage target discovery and drug development biotech company focused on immuno-oncology. The company leverages a proprietary and scientifically validated (through external partners) spatial-mapping technology platform called SPARTA (Spatial Processing And Regional Tissue Analysis) that collects biological information from cellular interactions and integrates this information with genomic/transcriptomic data to identify novel drug targets. Our first program aims to develop an antibody therapy that: i) targets ~ 30-50% of nonresponsive, "hot" tumors, ii) targets a largely unexplored cell regulator of tumor immunity and iii) works by removing local immunosuppression from "hot" tumors.